Calliditas Therapeutics: Q2 Earnings Insights
Calliditas Therapeutics (NASDAQ:CALT) reported its Q2 earnings results on Thursday, August 18, 2022 at 01:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 18, 2022
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.
A Preview Of Calliditas Therapeutics Earnings
Calliditas Therapeutics (NASDAQ:CALT) is set to give its latest quarterly earnings report on Thursday, 2022-08-18. Here's what investors need to know before the announcement.
89 Biggest Movers From Friday
Gainers
Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
33 Stocks Moving In Friday’s Mid-Day Session
Gainers
Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
20 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Decisionpoint Systems, Inc. (NASDAQ: DPSI) rose 47.2% to $7.02 in pre-market trading after jumping around 19% on Tuesday. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.
Earnings Scheduled For May 18, 2022
Companies Reporting Before The Bell
• Sypris Solutions (NASDAQ:SYPR) is projected to report earnings for its first quarter.
Calliditas Expects EMA’s CHMP Opinion For Nefecon In Q2
Calliditas Therapeutics AB (NASDAQ:CALT) says that the opinion of the Committee for Medicinal Products for Human Use (CHMP) of…